| Literature DB >> 35712327 |
James Mooney1, Nicholas Erickson1, Arsalaan Salehani1, Nick Laskay1, Anil Mahavadi1, Adeel Ilyas1, Bipul Mainali2, Nitin Agarwal3, Jakub Godzik1.
Abstract
Background: While general anesthesia (GA) is the most commonly used anesthetic method during lumbar microendoscopic discectomy (MED), local ± epidural anesthesia (LA) has been gaining popularity as an alternate method. Theoretical advantages of LA include reduced morbidity of anesthesia and improved surgeon-patient communication facilitating less nerve root manipulation and yielding improved surgical outcomes. The objective of this systematic review is to examine the impact of anesthesia type on patient reported outcomes (PROs) and complications with MED.Entities:
Keywords: General anesthesia; Local/epidural anesthesia; Meta-analysis; Microendoscopic discectomy; Patient-reported outcomes; Spine; Surgical outcomes; Systematic review
Year: 2022 PMID: 35712327 PMCID: PMC9194459 DOI: 10.1016/j.xnsj.2022.100129
Source DB: PubMed Journal: N Am Spine Soc J ISSN: 2666-5484
Fig. 1Flow diagram depicting the literature review, search strategy and selection process.
Study characteristics – primary surgical outcomes and operative data.
| STUDY | Study Design | No. Patients | Mean Age (Std. Dev.) | Mean Follow-Up (months) | Complication Rate (%) | Durotomy Rate (%) | Recurrent Disc Herniation Rate (%) | Reoperation Rate (%) | Length of Surgery (mins) | Blood Loss (cc) |
|---|---|---|---|---|---|---|---|---|---|---|
| GENERAL ANESTHESIA | ||||||||||
| Gibson et al., 2017 | RCT | 70 | 39 (9.0) | 24 | 1.4 | 0.0 | 2.9 | 2.9 | 65 | NA |
| Patil, et al., 2018 | Retrospective | 300 | NA | 6 | 6.0 | 1.0 | 2.0 | 3.3 | 82 | NA |
| Song et al. 2021 | Retrospective | 116 | 49 (10.9) | 36 | 12.1 | 1.7 | 6.0 | NA | 81.1 | 71.3 |
| Yoon et al., 2012 | Prospective | 26 | 56.5 (NA) | 20 | 7.7 | 3.8 | 3.8 | 0.0 | 178.8 | 153.8 |
| Yang et al., 2021 | Retrospective | 19 | 48.5 (12.1) | 24 | 10.5 | 5.3 | NA | NA | 65 | NA |
| Porto et al. 2021 | Retrospective | 38 | 53.6 (16.3) | 7.7 | 2.6 | NA | 28.9 | 13.2 | 57.5 | NA |
| Liu et al., 2021 | Retrospective | 60 | 53.4 (14.3) | 20 | 20.0 | 0.0 | 0.0 | 3.3 | 51.1 | 39.83 |
| Yu et al., 2021 | Retrospective | 421 | 40.1 (12.4) | 31.7 | 12.8 | 1.4 | 5.0 | 4.0 | 69.4 | 45.2 |
| Ren et al., 2020 | Prospective | 51 | 42 (11.6) | 36 | 9.8 | 0.0 | 7.8 | NA | 99.2 | NA |
| Liu et al., 2018 | Retrospective | 63 | 33.1 (6.7) | 29.6 | 9.5 | 4.8 | 3.2 | 3.2 | 57 | 23 |
| Li et al. 2015 | Retrospective | 30 | 37.8 (6.6) | 15.4 | 0.0 | 0.0 | 0.0 | 0.0 | 58.5 | NA |
| Kunert et al., 2010 | Retrospective | 13 | 34 (10.0) | 21 | 0.0 | 0.0 | 0.0 | 0.0 | 78 | NA |
| Righesso et al., 2007 | RCT | 21 | 42 (10.7) | 36.2 | 14.3 | 4.8 | 4.8 | 4.8 | 82.6 | 50 |
| Ranjan et al., 2006 | Prospective | 107 | NA | 12.9 | 6.5 | 1.9 | 1.9 | 0.9 | 120 | NA |
| LOCAL ± EPIDURAL ANESTHESIA | ||||||||||
| Abudurexiti et al., 2018 | Prospective | 134 | 36.3 (8.6) | 6 | 8.2 | 0.7 | NA | NA | 85.0 | 137.0 |
| Song et al., 2017 | Case/Control | 30 | 53.6 (6.4) | 18 | NA | NA | NA | NA | 76.6 | 100.7 |
| Jing et al., 2021 | Retrospective | 31 | 50.2 (9.4) | 24 | 19.4 | 3.2 | 3.2 | NA | 61.7 | 30.6 |
| Pang et al., 2020 | Retrospective | 48 | 45.3 (6.4) | 6 | 4.2 | 0.0 | 2.1 | NA | 72.6 | 35.4 |
| Chen et al., 2020 | RCT | 111 | 41 (10.8) | 24 | 9.9 | 2.7 | 4.5 | 4.5 | 100.2 | NA |
| Liu et al., 2010 | Retrospective | 82 | 42.1 (10.2) | 77.04 | 2.4 | 0.0 | 0.0 | 2.4 | NA | NA |
| Zhou et al., 2009 | Retrospective | 151 | 39 (NA) | 60 | 5.3 | 3.3 | 3.3 | 3.3 | NA | NA |
| Wu et al., 2006 | Retrospective | 873 | 41.5 (NA) | 28 | 4.0 | 1.6 | 0.9 | 2.3 | 56.0 | 44.0 |
| Chen et al., 2018 | RCT | 73 | 40.7 (11.1) | 12 | 12.3 | 1.4 | 4.1 | 4.1 | 91.7 | NA |
RCT – randomized control trial
Assessment of the quality of included studies according to the Newcastle-Ottawa quality assessment scale for non-RCTs.
| STUDY | Representativeness of Cohort | Selection of the Non-Exposed Cohort | Ascertainment of Exposure | Outcome of Interest | Comparability of Cohorts | Assessment of Outcome | Adequate Duration of Follow-Up | Adequate Follow-up of Cohort |
|---|---|---|---|---|---|---|---|---|
| GENERAL | ||||||||
| Patil, et al., 2018 | * | - | * | * | - | * | * | * |
| Song et al. 2021 | * | - | * | * | - | * | * | * |
| Yoon et al., 2012 | * | - | * | * | - | * | * | * |
| Yang et al., 2021 | * | - | * | * | - | * | * | * |
| Porto et al. 2021 | * | * | * | * | - | * | * | * |
| Liu et al., 2021 | * | - | * | * | - | * | * | * |
| Yu et al., 2021 | * | - | * | * | * | * | * | * |
| Ren et al., 2020 | * | - | * | * | * | * | * | * |
| Liu et al., 2018 | * | - | * | * | - | * | * | * |
| Li et al. 2015 | * | * | * | * | * | * | * | * |
| Kunert et al., 2010 | * | - | * | * | - | * | * | * |
| Ranjan et al., 2006 | * | - | * | * | * | * | * | * |
| LOCAL ± EPIDURAL | ||||||||
| Abudurexiti et al., 2018 | * | - | * | * | - | * | * | * |
| Song et al., 2017 | * | * | * | * | * | * | * | * |
| Jing et al., 2021 | * | * | * | * | * | * | * | * |
| Pang et al., 2020 | * | - | * | * | - | * | * | * |
| Liu et al., 2010 | * | * | * | * | * | * | * | * |
| Zhou et al., 2009 | * | - | * | * | - | * | * | * |
| Wu et al., 2006 | * | * | * | * | * | * | * | * |
Assessment of the quality of included studies according to the newcastle-ottawa quality assessment scale for RCTs.
| Selection | Comparability | Exposure | ||||||
|---|---|---|---|---|---|---|---|---|
| STUDY | Case Definition | Case Representativeness | Selection of Controls | Definition of Controls | Comparability | Ascertainment of Exposure | Same Method for Cases and Controls | Non-response Rate |
| GENERAL | ||||||||
| Gibson et al., 2017 | * | * | * | * | * | * | * | * |
| Righesso et al., 2007 | * | * | * | * | * | * | * | * |
| LOCAL ± EPIDURAL | ||||||||
| Chen et al., 2020 | * | * | * | * | * | * | * | * |
| Chen et al., 2018 | * | * | * | * | * | * | * | * |
Fig. 2Forest plots of complication incidence in MED with GA and LA.
Fig. 3Forest plots of durotomy incidence in MED with GA and LA.
Fig. 4Forest plots of reoperation incidence in MED with GA and LA.
Baseline age and patient-reported outcomes.
| LOCAL ± EPIDURAL | GENERAL | ||||||
|---|---|---|---|---|---|---|---|
| Parameter | # Studies Pooled | Pooled Value | SD | # Studies Pooled | General | SD | |
| Age | 7 | 44.1 | 7.5 | 11 | 42.8 | 8.1 | 0.69 |
| VAS back | 3 | 4.9 | 4.8 | 8 | 4.5 | 1.8 | 0.78 |
| VAS leg | 3 | 5.9 | 1.5 | 8 | 6.7 | 1.2 | 0.12 |
| JOA | 1 | 12.3 | 0.3 | 1 | 10.9 | 0.3 | |
| SF-36 PCS | 2 | 52.6 | 3.5 | 3 | 50.4 | 30.9 | 0.78 |
| ODI | 7 | 45.7 | 20.3 | 8 | 51.5 | 18.9 | 0.49 |
SD – standard deviation; VAS – visual analog scale; JOA – Japanese Orthopedic Association score; ODI – Oswestry Disability Index; SF-36 PCS – 36-item short form physical component score
Changes in patient-reported outcomes – preoperative, postoperative and last follow-up.
| PRE-OPERATIVE | FIRST POSTOPERATIVE | LAST FOLLOW-UP | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PRO | # Studies Pooled | Pooled Value | SD | # Studies Pooled | Pooled Value | SD | # Studies Pooled | Pooled Value | SD | ||
| LOCAL ± EPIDURAL | |||||||||||
| VAS back | 3 | 4.8 | 3 | 1.3 | 0.33 | 3 | 2.8 | 0.3 | |||
| VAS leg | 3 | 1.5 | 3 | 1.0 | 3 | 2.8 | 0.06 | ||||
| JOA | 1 | 0.3 | NA | NA | NA | 1 | 0.3 | ||||
| ODI | 7 | 20.3 | 5 | 10.3 | 7 | 12.7 | |||||
| SF-36 PCS | 2 | 3.5 | 1 | 1.6 | 1 | 0.5 | |||||
| GENERAL | |||||||||||
| VAS back | 8 | 1.8 | 5 | 1.4 | 0.14 | 8 | 1.3 | ||||
| VAS leg | 8 | 1.2 | 5 | 0.8 | 8 | 1.1 | |||||
| JOA | 1 | 0.3 | NA | NA | NA | 1 | 0.1 | ||||
| ODI | 8 | 18.9 | 5 | 11.1 | 8 | 9.0 | |||||
| SF-36 PCS | 3 | 30.9 | 2 | 23.8 | 0.53 | 3 | 55.6 | 0.53 | |||
SD – standard deviation; VAS – visual analog scale; JOA – Japanese Orthopedic Association score; ODI – Oswestry Disability Index;
SF-36 PCS – 36-item short form physical component score